Carbopol 974P Completed Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00074425BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women